[HTML][HTML] Mitochondrial regulation of diabetic kidney disease
DL Galvan, K Mise, FR Danesh - Frontiers in Medicine, 2021 - frontiersin.org
The role and nature of mitochondrial dysfunction in diabetic kidney disease (DKD) has been
extensively studied. Yet, the molecular drivers of mitochondrial remodeling in DKD are …
extensively studied. Yet, the molecular drivers of mitochondrial remodeling in DKD are …
[HTML][HTML] Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease
…, Y Matsumoto, P Thanai, N Suzuki, K Mise… - Nature …, 2019 - nature.com
Diabetic kidney disease is a major cause of renal failure that urgently necessitates a breakthrough
in disease management. Here we show using untargeted metabolomics that levels of …
in disease management. Here we show using untargeted metabolomics that levels of …
Prognostic value of tubulointerstitial lesions, urinary N-acetyl-β-D-glucosaminidase, and urinary β2-microglobulin in patients with type 2 diabetes and biopsy–proven …
K Mise, J Hoshino, T Ueno, R Hazue… - Clinical Journal of the …, 2016 - journals.lww.com
Results The median follow-up period was 2.3 years (interquartile range, 1.1–5.3), and the
primary outcome was noted in 94 patients. Mean eGFR was 46.3±23.2 ml/min per 1.73 m 2, …
primary outcome was noted in 94 patients. Mean eGFR was 46.3±23.2 ml/min per 1.73 m 2, …
Nonproteinuric versus proteinuric phenotypes in diabetic kidney disease: a propensity score–matched analysis of a nationwide, biopsy-based cohort study
…, K Samejima, K Kohagura, Y Shibagaki, K Mise… - Diabetes …, 2019 - Am Diabetes Assoc
OBJECTIVE Clinicopathological characteristics, renal prognosis, and mortality in patients
with type 2 diabetes and reduced renal function without overt proteinuria are scarce. …
with type 2 diabetes and reduced renal function without overt proteinuria are scarce. …
Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy
K Mise, J Hoshino, Y Ubara, K Sumida… - Nephrology Dialysis …, 2014 - academic.oup.com
Background A new classification of diabetic nephropathy was reported by Tervaert et al., but
the association between pathological findings and the clinical outcomes remains unclear. …
the association between pathological findings and the clinical outcomes remains unclear. …
Shaping up mitochondria in diabetic nephropathy
K Mise, DL Galvan, FR Danesh - Kidney360, 2020 - journals.lww.com
Mitochondrial medicine has experienced significant progress in recent years and is expected
to grow significantly in the near future, yielding many opportunities to translate novel bench …
to grow significantly in the near future, yielding many opportunities to translate novel bench …
Nationwide multicentre kidney biopsy study of Japanese patients with type 2 diabetes
…, K Kohagura, D Ogawa, K Mise… - Nephrology Dialysis …, 2018 - academic.oup.com
Background The clinical and pathologic manifestations of nephropathy due to type 2 diabetes
are diverse, but large-scale pathologic studies with long-term observations are limited. …
are diverse, but large-scale pathologic studies with long-term observations are limited. …
Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy
K Mise, J Hoshino, T Ueno, R Hazue… - Diabetes/metabolism …, 2015 - Wiley Online Library
Background The effect of clinical and pathological parameters on the estimated glomerular
filtration rate (eGFR) decline has not been investigated in patients with type 2 diabetes and …
filtration rate (eGFR) decline has not been investigated in patients with type 2 diabetes and …
A pathological scoring system to predict renal outcome in diabetic nephropathy
J Hoshino, K Mise, T Ueno, A Imafuku… - American Journal of …, 2015 - karger.com
Background: With the association between diabetic nephropathy (DN) and renal outcome
being increasingly clear, we aimed at creating a new DN pathological scoring system that …
being increasingly clear, we aimed at creating a new DN pathological scoring system that …
[HTML][HTML] Quality of life of patients with ADPKD—Toranomon PKD QOL study: cross-sectional study
T Suwabe, Y Ubara, K Mise, M Kawada, S Hamanoue… - BMC nephrology, 2013 - Springer
Background The quality of life (QOL) of patients with autosomal dominant polycystic kidney
disease (ADPKD) has not been investigated well. This study was performed to clarify the …
disease (ADPKD) has not been investigated well. This study was performed to clarify the …